Skip to content
#
Title
1

Code Blue: The Impact of Emergency Pharmacists on Resuscitation Outcomes

2

Antithrombotic Resumption After Intracranial Hemorrhage

3

Norepinephrine as the Preferred Vasopressor After Cardiac Arrest

4

Prolonged Beta-Lactam Infusion Strategies in Sepsis: A Deeper Dive

5

Ketamine During OAT Initiation: Can It Help in the Fentanyl Era?

6

Time Is Blood: Why Early TXA Saves Lives in Trauma

7

Blood Pressure Management in Acute Intracerebral Hemorrhage

8

Clinical Management of Toxicological Seizures

9

Tenecteplase vs Alteplase: The Evolving Standard for Ischemic Stroke

10

Pharmacological Priorities in Emergency Upper Gastrointestinal Bleeding

11

Is Ondansetron Really Dangerous? A Deep Dive into the Data

12

Safety of Co-administering Olanzapine and Benzodiazepines for Acute Agitation

13

Corticosteroids in Severe Pneumonia: The CAPE COD Debate

14

Hypertonic Saline and Furosemide in Acute Heart Failure Management

15

CCM 2026 Surviving Sepsis Campaign Guidelines: Precision Pharmacotherapy Unpacked

16

Essential Clinical Pearls for DOAC Therapy

17

Critical Care Antibiotic Pharmacokinetics and Dosing Strategies

18

Ketamine for Rapid Control of Excited Delirium

19

ACLS Medications 2025: What the AHA Guidelines Really Say

20

Still Febrile: When Ongoing Fevers Don’t Mean Treatment Failure

21

When Medications Fail: Can Keto Stop Seizures?

22

Ketamine and Second-Line Agents in Status Epilepticus Management

23

From Rate to Rhythm: Why Early Treatment Changes Atrial Fibrillation Outcomes

24

When Heart Failure Improves...What Comes Next?

25

Ketamine as a Neuroprotective Agent Following Cardiac Arrest

26

Medetomidine: Clinical Realities of a New Illicit Drug Toxidrome

27

Rethinking Rate Versus Rhythm Control in Atrial Fibrillation

28

The RSI Trial: Ketamine Versus Etomidate

29

Sodium Content in Common ED Antibiotics: A Hidden Risk in CHF

30

Lithium Toxicity, Interactions, and SILENT Syndrome

31

The Imperfections of Creatinine Clearance in Drug Dosing

32

Rethinking Beta-Blockers After MI

33

Optimizing Piperacillin-Tazobactam Dosing for Pseudomonas

34

Drug Protein Binding and Clinical Implications

35

Rocketamine vs. Keturonium: Managing Rapid Sequence Intubation

36

Anticoagulation in Chronic Kidney Disease

37

SQuID Protocol in Mild-Moderate DKA

38

Rapid Antiseizure Medication Administration

39

Warfarin and Antibiotic Interactions

40

Tranexamic Acid Unpacked: Evidence vs. Expectations

41

Tranexamic Acid: The 90-Minute Trauma Window?

42

BRASH Syndrome

43

Sliding Scale Furosemide for CHF

44

Pharmacotherapy for Insomnia

45

Anticoagulation in Cirrhosis

46

Gabapentin vs. Pregabalin for Chronic Neuropathic Pain

47

Antiemetics Uncovered: Side Effects, Interactions, and Clinical Pearls

48

Status Epilepticus Treatment Approach

49

Aspirin for Venous Thromboembolism Prophylaxis in Orthopedic Trauma

50

IV Push Antibiotics in the Emergency Department

51

Rapid Buprenorphine Induction with Low-Dose Naloxone

52

Anticoagulant and Antiplatelet Reversal

53

Liver Assessment and Drug Impact

54

Toxicology Key Principles

55

Pharmacists and Emergency Code Response

56

Diuretic Resistance in Congestive Heart Failure

57

Levetiracetam Dosing for Refractory Status Epilepticus

58

Phenobarbital for Alcohol Withdrawal

59

ActionADE Unpacked

60

Acute GI Bleeding

61

Advanced Trauma Life Support

62

Hyponatremia

63

Status Epilepticus

64

ACLS_ Algorithms and Pharmacology for Cardiac Resuscitation

65

Diabetic Crises: DKA and HHS

66

Sepsis, Shock, and Adrenal Insufficiency

67

Sublingual Levodopa

68

Acute Stroke

69

Rapid Sequence Intubation